Deeper Dive: Understanding Halozyme Therapeutics Inc. (HALO) Through its Various Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Halozyme Therapeutics Inc. (NASDAQ: HALO) closed at $51.30 in the last session, down -1.38% from day before closing price of $52.02. In other words, the price has decreased by -$1.38 from its previous closing price. On the day, 1.04 million shares were traded. HALO stock price reached its highest trading level at $52.09 during the session, while it also had its lowest trading level at $50.68.

Ratios:

We take a closer look at HALO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.41. For the most recent quarter (mrq), Quick Ratio is recorded 5.36 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 8.44.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on June 07, 2024, Downgraded its rating to Neutral and sets its target price to $51 from $48 previously.

On February 29, 2024, TD Cowen started tracking the stock assigning a Outperform rating and target price of $54.

On July 24, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $61.H.C. Wainwright initiated its Buy rating on July 24, 2023, with a $61 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 28 ’24 when LaBrosse Nicole sold 10,000 shares for $52.04 per share. The transaction valued at 520,400 led to the insider holds 15,480 shares of the business.

LaBrosse Nicole sold 10,000 shares of HALO for $519,340 on Jun 27 ’24. The SVP, CHIEF FINANCIAL OFFICER now owns 15,480 shares after completing the transaction at $51.93 per share. On Jun 26 ’24, another insider, LaBrosse Nicole, who serves as the SVP, CHIEF FINANCIAL OFFICER of the company, sold 10,000 shares for $51.82 each. As a result, the insider received 518,200 and left with 15,480 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 6620777984 and an Enterprise Value of 7598347264. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.22, and their Forward P/E ratio for the next fiscal year is 10.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.57 while its Price-to-Book (P/B) ratio in mrq is 36.69. Its current Enterprise Value per Revenue stands at 8.805 whereas that against EBITDA is 16.575.

Stock Price History:

The Beta on a monthly basis for HALO is 1.27, which has changed by 0.4070214 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, HALO has reached a high of $53.22, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is 13.40%, while the 200-Day Moving Average is calculated to be 29.13%.

Shares Statistics:

According to the various share statistics, HALO traded on average about 1.17M shares per day over the past 3-months and 1493230 shares per day over the past 10 days. A total of 126.77M shares are outstanding, with a floating share count of 125.88M. Insiders hold about 1.10% of the company’s shares, while institutions hold 97.85% stake in the company. Shares short for HALO as of 1718323200 were 9308538 with a Short Ratio of 7.94, compared to 1715731200 on 8558777. Therefore, it implies a Short% of Shares Outstanding of 9308538 and a Short% of Float of 9.8900005.

Most Popular